Literature DB >> 29794022

YAP Controls Endothelial Activation and Vascular Inflammation Through TRAF6.

Yang Lv1,2, Kyungho Kim3, Yue Sheng4, Jaehyung Cho3, Zhijian Qian4, You-Yang Zhao5,5,6, Gang Hu2, Duojia Pan7, Asrar B Malik3, Guochang Hu8,3.   

Abstract

RATIONALE: Microvascular inflammation and endothelial dysfunction secondary to unchecked activation of endothelium play a critical role in the pathophysiology of sepsis and organ failure. The intrinsic signaling mechanisms responsible for dampening excessive activation of endothelial cells are not completely understood.
OBJECTIVE: To determine the central role of YAP (Yes-associated protein), the major transcriptional coactivator of the Hippo pathway, in modulating the strength and magnitude of endothelial activation and vascular inflammation. METHODS AND
RESULTS: Endothelial-specific YAP knockout mice showed increased basal expression of E-selectin and ICAM (intercellular adhesion molecule)-1 in endothelial cells, a greater number of adherent neutrophils in postcapillary venules and increased neutrophil counts in bronchoalveolar lavage fluid. Lipopolysaccharide challenge of these mice augmented NF-κB (nuclear factor-κB) activation, expression of endothelial adhesion proteins, neutrophil and monocyte adhesion to cremaster muscle venules, transendothelial neutrophil migration, and lung inflammatory injury. Deletion of YAP in endothelial cells also markedly augmented the inflammatory response and cardiovascular dysfunction in a polymicrobial sepsis model induced by cecal ligation and puncture. YAP functioned by interacting with the E3 ubiquitin-protein ligase TLR (Toll-like receptor) signaling adaptor TRAF6 (tumor necrosis factor receptor-associated factor 6) to ubiquitinate TRAF6, and thus promoted TRAF6 degradation and modification resulting in inhibition of NF-κB activation. TRAF6 depletion in endothelial cells rescued the augmented inflammatory phenotype in mice with endothelial cell-specific deletion of YAP.
CONCLUSIONS: YAP modulates the activation of endothelial cells and suppresses vascular inflammation through preventing TRAF6-mediated NF-κB activation and is hence essential for limiting the severity of sepsis-induced inflammation and organ failure.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  E-selectin; acute lung injury; endothelial cells; neutrophils; sepsis; ubiquitination

Mesh:

Substances:

Year:  2018        PMID: 29794022      PMCID: PMC6014930          DOI: 10.1161/CIRCRESAHA.118.313143

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  48 in total

Review 1.  Ubiquitin signalling in the NF-kappaB pathway.

Authors:  Zhijian J Chen
Journal:  Nat Cell Biol       Date:  2005-08       Impact factor: 28.824

2.  MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.

Authors:  R Medzhitov; P Preston-Hurlburt; E Kopp; A Stadlen; C Chen; S Ghosh; C A Janeway
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

3.  The Hippo-YAP signaling pathway and contact inhibition of growth.

Authors:  Barry M Gumbiner; Nam-Gyun Kim
Journal:  J Cell Sci       Date:  2014-02-15       Impact factor: 5.285

4.  Hippo pathway activity influences liver cell fate.

Authors:  Dean Yimlamai; Constantina Christodoulou; Giorgio G Galli; Kilangsungla Yanger; Brian Pepe-Mooney; Basanta Gurung; Kriti Shrestha; Patrick Cahan; Ben Z Stanger; Fernando D Camargo
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

5.  Transduction of mechanical and cytoskeletal cues by YAP and TAZ.

Authors:  Georg Halder; Sirio Dupont; Stefano Piccolo
Journal:  Nat Rev Mol Cell Biol       Date:  2012-08-16       Impact factor: 94.444

6.  Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65.

Authors:  Elizabeth M Morin-Kensicki; Brian N Boone; Michael Howell; Jaclyn R Stonebraker; Jeremy Teed; James G Alb; Terry R Magnuson; Wanda O'Neal; Sharon L Milgram
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

7.  Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes.

Authors:  F X Zhang; C J Kirschning; R Mancinelli; X P Xu; Y Jin; E Faure; A Mantovani; M Rothe; M Muzio; M Arditi
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

8.  YAP1 increases organ size and expands undifferentiated progenitor cells.

Authors:  Fernando D Camargo; Sumita Gokhale; Jonathan B Johnnidis; Dongdong Fu; George W Bell; Rudolf Jaenisch; Thijn R Brummelkamp
Journal:  Curr Biol       Date:  2007-11-01       Impact factor: 10.834

Review 9.  All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction.

Authors:  Jee Y Chung; Young Chul Park; Hong Ye; Hao Wu
Journal:  J Cell Sci       Date:  2002-02-15       Impact factor: 5.285

10.  Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow.

Authors:  P A Koni; S K Joshi; U A Temann; D Olson; L Burkly; R A Flavell
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

View more
  45 in total

1.  TRAF6 regulates YAP signaling by promoting the ubiquitination and degradation of MST1 in pancreatic cancer.

Authors:  Jian-Ang Li; Tiantao Kuang; Ning Pu; Yuan Fang; Xu Han; Lei Zhang; Xuefeng Xu; Wenchuan Wu; Dansong Wang; Wenhui Lou; Yefei Rong
Journal:  Clin Exp Med       Date:  2019-01-23       Impact factor: 3.984

2.  SAA1 regulates pro-labour mediators in term labour by activating YAP pathway.

Authors:  Yanmin Jiang; Li Pin; Weiqun Shi; Qian Huang; Lele Wang; Huishu Liu
Journal:  Mol Cell Biochem       Date:  2021-03-15       Impact factor: 3.396

3.  Tubule-Specific Mst1/2 Deficiency Induces CKD via YAP and Non-YAP Mechanisms.

Authors:  Chunhua Xu; Li Wang; Yu Zhang; Wenling Li; Jinhong Li; Yang Wang; Chenling Meng; Jinzhong Qin; Zhi-Hua Zheng; Hui-Yao Lan; Kingston King-Lun Mak; Yu Huang; Yin Xia
Journal:  J Am Soc Nephrol       Date:  2020-04-06       Impact factor: 10.121

4.  TLR4 is required for macrophage efferocytosis during resolution of ventilator-induced lung injury.

Authors:  Kai Su; Lulong Bo; Chunling Jiang; Xiaoming Deng; You-Yang Zhao; Richard D Minshall; Guochang Hu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-08-18       Impact factor: 6.011

5.  YAP promotes the activation of NLRP3 inflammasome via blocking K27-linked polyubiquitination of NLRP3.

Authors:  Dan Wang; Yening Zhang; Xueming Xu; Jianfeng Wu; Yue Peng; Jing Li; Ruiheng Luo; Lingmin Huang; Liping Liu; Songlin Yu; Ningjie Zhang; Ben Lu; Kai Zhao
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

6.  Therapeutic Potential of Extracellular Vesicles for Sepsis Treatment.

Authors:  Stephanie M Kronstadt; Alex E Pottash; Daniel Levy; Sheng Wang; Wei Chao; Steven M Jay
Journal:  Adv Ther (Weinh)       Date:  2021-04-29

7.  Transcriptional Modulation of the Hippo Signaling Pathway by Drugs Used to Treat Bipolar Disorder and Schizophrenia.

Authors:  Bruna Panizzutti; Chiara C Bortolasci; Briana Spolding; Srisaiyini Kidnapillai; Timothy Connor; Mark F Richardson; Trang T T Truong; Zoe S J Liu; Gerwyn Morris; Laura Gray; Jee Hyun Kim; Olivia M Dean; Michael Berk; Ken Walder
Journal:  Int J Mol Sci       Date:  2021-07-02       Impact factor: 5.923

8.  YAP expression in endothelial cells prevents ventilator-induced lung injury.

Authors:  Kai Su; Jianguo Wang; Yang Lv; Ming Tian; You-Yang Zhao; Richard D Minshall; Guochang Hu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-02-10       Impact factor: 5.464

9.  Il12a Deletion Aggravates Sepsis-Induced Cardiac Dysfunction by Regulating Macrophage Polarization.

Authors:  Zhen Wang; Menglin Liu; Di Ye; Jing Ye; Menglong Wang; Jianfang Liu; Yao Xu; Jishou Zhang; Mengmeng Zhao; Yongqi Feng; Shuwan Xu; Wei Pan; Zhen Luo; Dan Li; Jun Wan
Journal:  Front Pharmacol       Date:  2021-07-02       Impact factor: 5.810

10.  Artesunate combined with verteporfin inhibits uveal melanoma by regulation of the MALAT1/yes-associated protein signaling pathway.

Authors:  Xudong Jiu; Yang Liu; Jin Wen
Journal:  Oncol Lett       Date:  2021-06-09       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.